Favourable effect of the sodium‐glucose co‐transporter‐2 inhibitor canagliflozin plus the dipeptidyl peptidase‐4 inhibitor teneligliptin in combination on glycaemic fluctuation: An open‐label, prospective, randomized, parallel‐group comparison trial (the CALMER study)

This multicentre, prospective, randomized, open‐label, blinded‐endpoint, parallel‐group, short‐term (4–5 weeks) controlled trial was conducted to investigate the superiority of the effect of reducing mean amplitude of glycaemic excursions (MAGE) during meal tolerance tests (MTTs) for the combination...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Kyu Yong, Nomoto, Hiroshi, Nakamura, Akinobu, Kawata, Shinichiro, Sugawara, Hajime, Takeuchi, Jun, Nagai, So, Tsuchida, Kazuhisa, Omori, Kazuno, Yokoyama, Hiroki, Manda, Naoki, Kurihara, Yoshio, Aoki, Shin, Atsumi, Tatsuya, Miyoshi, Hideaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2019
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7065098/
https://www.ncbi.nlm.nih.gov/pubmed/31486230
http://dx.doi.org/10.1111/dom.13879

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7065098/
https://www.ncbi.nlm.nih.gov/pubmed/31486230
http://dx.doi.org/10.1111/dom.13879

Ejemplares similares